West Pharmaceutical Services, Inc. (WST)
USD 325.32
(-2.67%)
USD 325.32
(-2.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 309 Million USD | -2.8% |
| 2022 | 317.9 Million USD | -2.27% |
| 2021 | 325.3 Million USD | -0.12% |
| 2020 | 325.7 Million USD | -1.09% |
| 2019 | 329.3 Million USD | 67.92% |
| 2018 | 196.1 Million USD | -0.46% |
| 2017 | 197 Million USD | -13.82% |
| 2016 | 228.6 Million USD | -23.34% |
| 2015 | 298.2 Million USD | -11.43% |
| 2014 | 336.7 Million USD | -9.85% |
| 2013 | 373.5 Million USD | -9.23% |
| 2012 | 411.5 Million USD | 17.77% |
| 2011 | 349.4 Million USD | -2.51% |
| 2010 | 358.4 Million USD | -5.58% |
| 2009 | 379.6 Million USD | -1.66% |
| 2008 | 386 Million USD | -2.3% |
| 2007 | 395.1 Million USD | 67.2% |
| 2006 | 236.3 Million USD | -15.91% |
| 2005 | 281 Million USD | 74.75% |
| 2004 | 160.8 Million USD | -8.11% |
| 2003 | 175 Million USD | 0.0% |
| 2002 | 175 Million USD | -9.33% |
| 2001 | 193 Million USD | -3.21% |
| 2000 | 199.4 Million USD | 16.54% |
| 1999 | 171.1 Million USD | 21.26% |
| 1998 | 141.1 Million USD | 58.54% |
| 1997 | 89 Million USD | -9.55% |
| 1996 | 98.4 Million USD | -13.91% |
| 1995 | 114.3 Million USD | 97.75% |
| 1994 | 57.8 Million USD | 78.95% |
| 1993 | 32.3 Million USD | -23.28% |
| 1992 | 42.1 Million USD | -27.91% |
| 1991 | 58.4 Million USD | -25.61% |
| 1990 | 78.5 Million USD | 35.11% |
| 1989 | 58.1 Million USD | 5.44% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 202.6 Million USD | -2.93% |
| 2024 Q1 | 306.6 Million USD | -0.78% |
| 2024 Q2 | 314 Million USD | 2.41% |
| 2023 Q2 | 311.3 Million USD | -0.99% |
| 2023 FY | 309 Million USD | -2.8% |
| 2023 Q1 | 314.4 Million USD | -1.1% |
| 2023 Q3 | 306.8 Million USD | -1.45% |
| 2023 Q4 | 309 Million USD | 0.72% |
| 2022 Q1 | 331.2 Million USD | 1.81% |
| 2022 FY | 317.9 Million USD | -2.27% |
| 2022 Q4 | 317.9 Million USD | 6.0% |
| 2022 Q3 | 299.9 Million USD | -9.8% |
| 2022 Q2 | 332.5 Million USD | 0.39% |
| 2021 FY | 325.3 Million USD | -0.12% |
| 2021 Q4 | 325.3 Million USD | 3.07% |
| 2021 Q3 | 315.6 Million USD | -1.19% |
| 2021 Q2 | 319.4 Million USD | -0.62% |
| 2021 Q1 | 321.4 Million USD | -1.32% |
| 2020 Q4 | 325.7 Million USD | 0.06% |
| 2020 Q1 | 327.3 Million USD | -0.61% |
| 2020 Q3 | 325.5 Million USD | -0.43% |
| 2020 Q2 | 326.9 Million USD | -0.12% |
| 2020 FY | 325.7 Million USD | -1.09% |
| 2019 Q4 | 329.3 Million USD | 22.69% |
| 2019 FY | 329.3 Million USD | 67.92% |
| 2019 Q1 | 273.1 Million USD | 39.27% |
| 2019 Q2 | 272.6 Million USD | -0.18% |
| 2019 Q3 | 268.4 Million USD | -1.54% |
| 2018 Q4 | 196.1 Million USD | -0.05% |
| 2018 Q2 | 196.4 Million USD | -0.81% |
| 2018 Q3 | 196.2 Million USD | -0.1% |
| 2018 Q1 | 198 Million USD | 0.51% |
| 2018 FY | 196.1 Million USD | -0.46% |
| 2017 Q2 | 229.5 Million USD | 0.39% |
| 2017 FY | 197 Million USD | -13.82% |
| 2017 Q4 | 197 Million USD | -14.27% |
| 2017 Q3 | 229.8 Million USD | 0.13% |
| 2017 Q1 | 228.6 Million USD | 0.0% |
| 2016 Q2 | 231.4 Million USD | -0.26% |
| 2016 FY | 228.6 Million USD | -23.34% |
| 2016 Q4 | 228.6 Million USD | -1.12% |
| 2016 Q3 | 231.2 Million USD | -0.09% |
| 2016 Q1 | 232 Million USD | -22.2% |
| 2015 FY | 298.2 Million USD | -11.43% |
| 2015 Q2 | 326.7 Million USD | -1.21% |
| 2015 Q1 | 330.7 Million USD | -1.78% |
| 2015 Q4 | 298.2 Million USD | -1.42% |
| 2015 Q3 | 302.5 Million USD | -7.41% |
| 2014 Q2 | 361.5 Million USD | -10.72% |
| 2014 FY | 336.7 Million USD | -9.85% |
| 2014 Q4 | 336.7 Million USD | -1.75% |
| 2014 Q1 | 404.9 Million USD | 8.41% |
| 2014 Q3 | 342.7 Million USD | -5.2% |
| 2013 FY | 373.5 Million USD | -9.23% |
| 2013 Q3 | 400 Million USD | 1.32% |
| 2013 Q2 | 394.8 Million USD | -8.21% |
| 2013 Q1 | 430.1 Million USD | 4.52% |
| 2013 Q4 | 373.5 Million USD | -6.63% |
| 2012 FY | 411.5 Million USD | 17.77% |
| 2012 Q4 | 411.5 Million USD | 2.52% |
| 2012 Q3 | 401.4 Million USD | 4.12% |
| 2012 Q2 | 385.5 Million USD | 1.07% |
| 2012 Q1 | 381.4 Million USD | 9.16% |
| 2011 Q3 | 378 Million USD | 1.2% |
| 2011 Q1 | 371 Million USD | 3.52% |
| 2011 Q4 | 349.4 Million USD | -7.57% |
| 2011 FY | 349.4 Million USD | -2.51% |
| 2011 Q2 | 373.5 Million USD | 0.67% |
| 2010 FY | 358.4 Million USD | -5.58% |
| 2010 Q1 | 369.4 Million USD | -2.69% |
| 2010 Q2 | 357.2 Million USD | -3.3% |
| 2010 Q3 | 370.7 Million USD | 3.78% |
| 2010 Q4 | 358.4 Million USD | -3.32% |
| 2009 Q2 | 390.2 Million USD | 0.59% |
| 2009 Q3 | 397 Million USD | 1.74% |
| 2009 Q4 | 379.6 Million USD | -4.38% |
| 2009 Q1 | 387.9 Million USD | 0.49% |
| 2009 FY | 379.6 Million USD | -1.66% |
| 2008 FY | 386 Million USD | -2.3% |
| 2008 Q1 | 417.5 Million USD | 5.67% |
| 2008 Q3 | 382.5 Million USD | -3.94% |
| 2008 Q4 | 386 Million USD | 0.92% |
| 2008 Q2 | 398.2 Million USD | -4.62% |
| 2007 Q3 | 393.6 Million USD | 2.31% |
| 2007 Q4 | 395.1 Million USD | 0.38% |
| 2007 Q2 | 384.7 Million USD | 2.02% |
| 2007 Q1 | 377.1 Million USD | 59.59% |
| 2007 FY | 395.1 Million USD | 67.2% |
| 2006 Q1 | 271 Million USD | -3.56% |
| 2006 Q3 | 241.1 Million USD | -7.23% |
| 2006 Q4 | 236.3 Million USD | -1.99% |
| 2006 FY | 236.3 Million USD | -15.91% |
| 2006 Q2 | 259.9 Million USD | -4.1% |
| 2005 Q1 | 152.7 Million USD | -5.04% |
| 2005 FY | 281 Million USD | 74.75% |
| 2005 Q2 | 278 Million USD | 82.06% |
| 2005 Q3 | 260.6 Million USD | -6.26% |
| 2005 Q4 | 281 Million USD | 7.83% |
| 2004 Q3 | 162.7 Million USD | 2.97% |
| 2004 FY | 160.8 Million USD | -8.11% |
| 2004 Q1 | 152.2 Million USD | -13.03% |
| 2004 Q2 | 158 Million USD | 3.81% |
| 2004 Q4 | 160.8 Million USD | -1.17% |
| 2003 Q4 | 175 Million USD | -2.18% |
| 2003 Q2 | 179.6 Million USD | 3.46% |
| 2003 Q3 | 178.9 Million USD | -0.39% |
| 2003 Q1 | 173.6 Million USD | -0.8% |
| 2003 FY | 175 Million USD | 0.0% |
| 2002 Q3 | 178.1 Million USD | -3.89% |
| 2002 Q2 | 185.3 Million USD | -0.59% |
| 2002 FY | 175 Million USD | -9.33% |
| 2002 Q4 | 175 Million USD | -1.74% |
| 2002 Q1 | 186.4 Million USD | -3.42% |
| 2001 Q1 | 209.1 Million USD | 4.86% |
| 2001 Q4 | 193 Million USD | -12.23% |
| 2001 FY | 193 Million USD | -3.21% |
| 2001 Q3 | 219.9 Million USD | 4.71% |
| 2001 Q2 | 210 Million USD | 0.43% |
| 2000 FY | 199.4 Million USD | 16.54% |
| 2000 Q4 | 199.4 Million USD | 3.58% |
| 2000 Q3 | 192.5 Million USD | 4.34% |
| 2000 Q1 | 130.7 Million USD | -23.61% |
| 2000 Q2 | 184.5 Million USD | 41.16% |
| 1999 FY | 171.1 Million USD | 21.26% |
| 1999 Q3 | 163.6 Million USD | -1.09% |
| 1999 Q4 | 171.1 Million USD | 4.58% |
| 1999 Q2 | 165.4 Million USD | 17.89% |
| 1999 Q1 | 140.3 Million USD | -0.57% |
| 1998 Q1 | 125.8 Million USD | 41.35% |
| 1998 Q2 | 111.6 Million USD | -11.29% |
| 1998 Q3 | 112.7 Million USD | 0.99% |
| 1998 Q4 | 141.1 Million USD | 25.2% |
| 1998 FY | 141.1 Million USD | 58.54% |
| 1997 Q3 | 90.4 Million USD | -0.66% |
| 1997 Q1 | 92.9 Million USD | -5.59% |
| 1997 Q2 | 91 Million USD | -2.05% |
| 1997 Q4 | 89 Million USD | -1.55% |
| 1997 FY | 89 Million USD | -9.55% |
| 1996 FY | 98.4 Million USD | -13.91% |
| 1996 Q4 | 98.4 Million USD | -8.8% |
| 1996 Q1 | 108.4 Million USD | -5.16% |
| 1996 Q3 | 107.9 Million USD | -6.98% |
| 1996 Q2 | 116 Million USD | 7.01% |
| 1995 Q2 | 124.3 Million USD | 46.58% |
| 1995 Q1 | 84.8 Million USD | 46.71% |
| 1995 Q4 | 114.3 Million USD | -4.51% |
| 1995 FY | 114.3 Million USD | 97.75% |
| 1995 Q3 | 119.7 Million USD | -3.7% |
| 1994 Q2 | 46.9 Million USD | 29.56% |
| 1994 Q3 | 50.3 Million USD | 7.25% |
| 1994 Q4 | 57.8 Million USD | 14.91% |
| 1994 FY | 57.8 Million USD | 78.95% |
| 1994 Q1 | 36.2 Million USD | 12.07% |
| 1993 Q2 | 40.7 Million USD | -1.93% |
| 1993 FY | 32.3 Million USD | -23.28% |
| 1993 Q4 | 32.3 Million USD | -15.67% |
| 1993 Q3 | 38.3 Million USD | -5.9% |
| 1993 Q1 | 41.5 Million USD | -1.43% |
| 1992 Q2 | 51.4 Million USD | -8.87% |
| 1992 Q4 | 42.1 Million USD | -15.12% |
| 1992 FY | 42.1 Million USD | -27.91% |
| 1992 Q3 | 49.6 Million USD | -3.5% |
| 1992 Q1 | 56.4 Million USD | -3.42% |
| 1991 Q3 | 63.4 Million USD | -8.12% |
| 1991 Q4 | 58.4 Million USD | -7.89% |
| 1991 Q1 | 79.1 Million USD | 0.76% |
| 1991 FY | 58.4 Million USD | -25.61% |
| 1991 Q2 | 69 Million USD | -12.77% |
| 1990 Q1 | 63.3 Million USD | 8.95% |
| 1990 Q2 | 73.3 Million USD | 15.8% |
| 1990 Q4 | 78.5 Million USD | 1.55% |
| 1990 Q3 | 77.3 Million USD | 5.46% |
| 1990 FY | 78.5 Million USD | 35.11% |
| 1989 FY | 58.1 Million USD | 5.44% |
| 1989 Q4 | 58.1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alcon Inc. | 5.14 Billion USD | 93.992% |
| AptarGroup, Inc. | 1.18 Billion USD | 73.917% |
| Baxter International Inc. | 14.36 Billion USD | 97.849% |
| Becton, Dickinson and Company | 15.87 Billion USD | 98.054% |
| Bausch + Lomb Corporation | 4.56 Billion USD | 93.227% |
| Haemonetics Corporation | 873.88 Million USD | 64.641% |
| Envista Holdings Corp | 1.65 Billion USD | 81.313% |
| ResMed Inc. | 873.93 Million USD | 64.643% |
| Teleflex Incorporated | 1.92 Billion USD | 83.959% |
| Warby Parker Inc. | 174.45 Million USD | -77.121% |